Now, combined with food inflation, rolling back to an already-inadequate benefit...
Republicans are scrambling to ban a controversial cost-effectiveness metric, QAL...
Novartis announced data Monday that could set up one of the biggest marketing ba...
New drugs for depression and new thinking are now transforming a field that has ...
The Ohio attorney general filed a lawsuit on Monday accusing three large pharmac...
At the Senate hearing with Moderna's CEO, Sen. Bernie Sanders put forth a provoc...
The FDA proposed cancer drug developers in most cases conduct more rigorous tria...
The FDA will convene a meeting of independent advisers to review a personalized ...
What happens once the disease you've been advocating for is no longer really the...
As many states look to restrict gender-affirming care, state legislator Leigh Fi...
New testing kits will allow health departments, grassroots groups, and individua...
Iovance is pursuing accelerated approval in advanced melanoma for the tumour inf...
Faced with such a disappointing approval number last year, manufacturers hope fo...
National Resilience expects the expanded capacity will help in securing the supp...
According to GlobalData’s Drugs database, early-stage therapies are focused on v...
Joenja’s approval was based on the data obtained from a Phase II/III clinical tr...
